Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of NAFT-600, applied once
daily for 2 weeks, when compared to placebo for 2 weeks in the treatment of subjects with
tinea pedis.
Phase:
Phase 3
Details
Lead Sponsor:
Merz North America, Inc. Merz Pharmaceuticals, LLC